IDEXX Laboratories Inc. (IDXX)

275.41
NASDAQ : Health Technology
Prev Close 273.07
Day Low/High 274.23 / 279.24
52 Wk Low/High 176.11 / 292.17
Avg Volume 372.00K
Exchange NASDAQ
Shares Outstanding 86.09M
Market Cap 23.51B
EPS 4.30
P/E Ratio 58.85
Div & Yield N.A. (N.A)
Bonds Call the Tune Today, Not Stocks: Cramer's 'Mad Money' Recap (Thursday 2/9/17)

Bonds Call the Tune Today, Not Stocks: Cramer's 'Mad Money' Recap (Thursday 2/9/17)

When bond yields rise, the economy roars and it's game on for industrials, banks and retailers, says Jim Cramer.

Cramer: Reward vs. Political Risk

Cramer: Reward vs. Political Risk

Trump has made it harder to decide how much volatility you can stand.

Jim Cramer -- Idexx Labs Isn't Done Rallying

Jim Cramer -- Idexx Labs Isn't Done Rallying

Idexx Laboratories beat on earnings per share and revenue expectations, but the trend is still good, Cramer said.

Amazon, Merck, Freshpet: Jim Cramer's Views

Amazon, Merck, Freshpet: Jim Cramer's Views

Cramer shares his views on the pajama traders, and talks turkey about pet stocks.

Jim Cramer's Top Takeaways: VCA, Johnson Controls, Adient

Jim Cramer's Top Takeaways: VCA, Johnson Controls, Adient

Cramer can't understand why shares of Johnson Controls spinoff Adient aren't trading higher.

These Stocks Are Too Hot, in a Bad Way : Jim Cramer's 'Mad Money' Recap

These Stocks Are Too Hot, in a Bad Way : Jim Cramer's 'Mad Money' Recap

Going into earnings what the market needs now is more negativity, Cramer says.

Cramer: Barking Up the Right Tree With Pet Health Stocks

Cramer: Barking Up the Right Tree With Pet Health Stocks

The Mars-VCA deal is yet another sign that pet health is a robust business.

Mars Makes 'Breakthrough Deal' With VCA Acquisition: More Squawk From Jim Cramer

Mars Makes 'Breakthrough Deal' With VCA Acquisition: More Squawk From Jim Cramer

Mars is making moves in 'one of the fastest growing secular stories in the world' with its acquisition of VCA, TheStreet's Jim Cramer said.

Jim Cramer on the Mars Deal for VCA

Jim Cramer on the Mars Deal for VCA

Jim Cramer says the deal between Mars and VCA is another example of how pet pampering is becoming big business.

Jim Cramer's Top Takeaways: Western Digital, Diamondback Energy, IDEXX Laboratories

Jim Cramer's Top Takeaways: Western Digital, Diamondback Energy, IDEXX Laboratories

From data storage and oil markets to the 'humanization of pets,' these stocks are worth a closer look.

Jim Cramer's 'Mad Money' Recap: How to Play Leapfrog in This Fast-Moving Market

Jim Cramer's 'Mad Money' Recap: How to Play Leapfrog in This Fast-Moving Market

Jim Cramer says stocks keep leapfrogging their peers in sectors like airlines and semiconductors.

'Mad Money' Lightning Round: Jim Cramer Likes Some Banks on a Pullback

'Mad Money' Lightning Round: Jim Cramer Likes Some Banks on a Pullback

Bank of America is a buy, Jim Cramer says. And Morgan Stanley is also cheap.

Jim Cramer's 'Mad Money' Recap: In This Market, Buyers Are Underneath

Jim Cramer's 'Mad Money' Recap: In This Market, Buyers Are Underneath

Jim Cramer says buyers just can't wait for this market to come down.

Jim Cramer -- Buy Zoetis, Idexx Over Freshpet

Jim Cramer -- Buy Zoetis, Idexx Over Freshpet

Jim Cramer says Freshpet is only a takeover play and suggests buying Zoetis or Idexx Labs instead.

'Mad Money' Lightning Round: Cramer's Been Behind MGM Resorts for a Long Time

'Mad Money' Lightning Round: Cramer's Been Behind MGM Resorts for a Long Time

MGM: 'I like the CEO and I like the REIT,' Jim Cramer says.

Jim Cramer's 'Mad Money' Recap: The Three Faces of the Stock Market

Jim Cramer's 'Mad Money' Recap: The Three Faces of the Stock Market

Know which stocks are interest-rate sensitive and which don't care, says Jim Cramer.

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

The animal health industry looks poised for growth, analysts say, and Idexx Laboratories IDXX stands to benefit.

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

Cramer is sticking with International Paper and likes Advanced Micro Devices.

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

This is not the time to sell in a panic, Cramer says.

5 Big Stocks to Buy Following Friday's Selloff

5 Big Stocks to Buy Following Friday's Selloff

These stocks have both short-term gain catalysts and longer-term growth potential.

Pets Are Big Business Now and These Stocks Are Behind the Trend

Pets Are Big Business Now and These Stocks Are Behind the Trend

TheStreet's Jim Cramer says the humanization of pets is a growing investment opportunity.

Pets Are Family Now and These Stocks Are Best in Show

Pets Are Family Now and These Stocks Are Best in Show

The humanization of pets has sent spending soaring, which has some pet-related stock seeing major benefits.

CMCSA, IDXX, ZTS: Jim Cramer's Views

CMCSA, IDXX, ZTS: Jim Cramer's Views

Cramer shares his views on the winners and losers of this earnings season. Comcast, Idexx Laboratories and Zoetis are among the stocks discussed.

Has IDEXX Labs Hit an Exhaustion Gap?

Has IDEXX Labs Hit an Exhaustion Gap?

It's best to stay nimble with this one.

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Cramer has seen enough in this earnings season to come to some conclusions on what's working and what isn't.

Cramer: Here's What to Embrace and What to Shun

Cramer: Here's What to Embrace and What to Shun

With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.

Barbarian At The Gate: IDEXX Laboratories (IDXX)

Barbarian At The Gate: IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

New Lifetime High Reached By IDEXX Laboratories (IDXX)

New Lifetime High Reached By IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a new lifetime high candidate

Trade-Ideas: IDEXX Laboratories (IDXX) Is Today's Strong And Under The Radar Stock

Trade-Ideas: IDEXX Laboratories (IDXX) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a strong and under the radar candidate

Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive

Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive

Cramer is faithful to pet care drug maker Zoetis and he prefers Danaher over its split-off sibling Fortive.

TheStreet Quant Rating: B+ (Buy)